In today’s recent session, 2.4 million shares of the ZyVersa Therapeutics Inc (NASDAQ:ZVSA) have been traded, and its beta is 0.55. Most recently the company’s share price was $1.10, and it changed around -$0.13 or -10.57% from the last close, which brings the market valuation of the company to $2.58M. ZVSA at last check was trading at a discount to its 52-week high of $42.38, offering almost -3752.73% off that amount. The share price’s 52-week low was $1.04, which indicates that the recent value has risen by an impressive 5.45% since then. We note from ZyVersa Therapeutics Inc’s average daily trading volume that its 10-day average is 6.81 million shares, with the 3-month average coming to 1.18 million.
ZyVersa Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended ZVSA as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. ZyVersa Therapeutics Inc is expected to report earnings per share of -2.73 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information
Instantly ZVSA has been showing red trend so far today with a performance of -10.57% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.2899 on recent trading dayincreased the stock’s daily price by 14.72%. The company’s shares are currently down -87.78% year-to-date, but still down -12.00% over the last five days. On the other hand, ZyVersa Therapeutics Inc (NASDAQ:ZVSA) is -50.00% down in the 30-day period. We can see from the shorts that 45485.0 shares have been sold at a short interest cover period of 0.19 day(s).
ZyVersa Therapeutics Inc (ZVSA) estimates and forecasts
ZyVersa Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -75.06 percent over the past six months and at a 97.65% annual growth rate that is well above the industry average of 18.10%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 99.74% in revenue this quarter, and will report an increase of 91.17% in the next quarter.
ZVSA Dividends
ZyVersa Therapeutics Inc’s next quarterly earnings report is expected to be released in December.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.61% of ZyVersa Therapeutics Inc shares, and 4.47% of them are in the hands of institutional investors. The stock currently has a share float of 4.50%.
Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024. The former held 5.04 shares worth $5597.0, making up 0.22% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 50.0 shares worth around $55.0, which represents about 0.00% of the total shares outstanding.
